These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 22338050

  • 1. Molecular and clinicopathologic characterization of AML with isolated trisomy 4.
    Bains A, Lu G, Yao H, Luthra R, Medeiros LJ, Sargent RL.
    Am J Clin Pathol; 2012 Mar; 137(3):387-94. PubMed ID: 22338050
    [Abstract] [Full Text] [Related]

  • 2. Trisomy 11 as an isolated abnormality in acute myeloid leukemia is associated with unfavorable prognosis but not with an NPM1 or KIT mutation.
    Alseraye FM, Zuo Z, Bueso-Ramos C, Wang S, Medeiros LJ, Lu G.
    Int J Clin Exp Pathol; 2011 Apr; 4(4):371-7. PubMed ID: 21577323
    [Abstract] [Full Text] [Related]

  • 3. Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia.
    Schlenk RF, Döhner K, Krauter J, Fröhling S, Corbacioglu A, Bullinger L, Habdank M, Späth D, Morgan M, Benner A, Schlegelberger B, Heil G, Ganser A, Döhner H, German-Austrian Acute Myeloid Leukemia Study Group.
    N Engl J Med; 2008 May 01; 358(18):1909-18. PubMed ID: 18450602
    [Abstract] [Full Text] [Related]

  • 4. FLT3 and NPM1 mutations in myelodysplastic syndromes: Frequency and potential value for predicting progression to acute myeloid leukemia.
    Bains A, Luthra R, Medeiros LJ, Zuo Z.
    Am J Clin Pathol; 2011 Jan 01; 135(1):62-9. PubMed ID: 21173125
    [Abstract] [Full Text] [Related]

  • 5. Prognostic significance of CEBPA mutations in a large cohort of younger adult patients with acute myeloid leukemia: impact of double CEBPA mutations and the interaction with FLT3 and NPM1 mutations.
    Green CL, Koo KK, Hills RK, Burnett AK, Linch DC, Gale RE.
    J Clin Oncol; 2010 Jun 01; 28(16):2739-47. PubMed ID: 20439648
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Clinical implications of non-A-type NPM1 and FLT3 mutations in patients with normal karyotype acute myeloid leukemia.
    Park BG, Chi HS, Park SJ, Min SK, Jang S, Park CJ, Kim DY, Lee JH, Lee JH, Lee KH.
    Acta Haematol; 2012 Jun 01; 127(2):63-71. PubMed ID: 22104247
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Amount of bone marrow blasts is strongly correlated to NPM1 and FLT3-ITD mutation rate in AML with normal karyotype.
    Haferlach T, Bacher U, Alpermann T, Haferlach C, Kern W, Schnittger S.
    Leuk Res; 2012 Jan 01; 36(1):51-8. PubMed ID: 21621842
    [Abstract] [Full Text] [Related]

  • 16. De novo acute myeloid leukemia with 20-29% blasts is less aggressive than acute myeloid leukemia with ≥30% blasts in older adults: a Bone Marrow Pathology Group study.
    Hasserjian RP, Campigotto F, Klepeis V, Fu B, Wang SA, Bueso-Ramos C, Cascio MJ, Rogers HJ, Hsi ED, Soderquist C, Bagg A, Yan J, Ochs R, Orazi A, Moore F, Mahmoud A, George TI, Foucar K, Odem J, Booth C, Morice W, DeAngelo DJ, Steensma D, Stone RM, Neuberg D, Arber DA.
    Am J Hematol; 2014 Nov 01; 89(11):E193-9. PubMed ID: 25042343
    [Abstract] [Full Text] [Related]

  • 17. Importance of early detection and follow-up of FLT3 mutations in patients with acute myeloid leukemia.
    Colovic N, Tosic N, Aveic S, Djuric M, Milic N, Bumbasirevic V, Colovic M, Pavlovic S.
    Ann Hematol; 2007 Oct 01; 86(10):741-7. PubMed ID: 17579862
    [Abstract] [Full Text] [Related]

  • 18. Prognostic factors in normal karyotype acute myeloid leukemia in the absence of the FLT3-ITD mutation.
    Jiang A, Jiang H, Brandwein J, Kamel-Reid S, Chang H.
    Leuk Res; 2011 Apr 01; 35(4):492-8. PubMed ID: 20684989
    [Abstract] [Full Text] [Related]

  • 19. Risk assessment in patients with acute myeloid leukemia and a normal karyotype.
    Bienz M, Ludwig M, Leibundgut EO, Mueller BU, Ratschiller D, Solenthaler M, Fey MF, Pabst T.
    Clin Cancer Res; 2005 Feb 15; 11(4):1416-24. PubMed ID: 15746041
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.